Search Results 91-100 of 13562 for isotretinoin

  1. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  2. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  3. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  4. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  5. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  6. A Study Assessing The Efficacy And Safety Of 2 Dosage Regimens Of Oral IPN60130 For FOP - Mayo Clinic

    Participants with prior treatment such as, but not limited to, imatinib, isotretinoin, or palovarotene may be enrolled 30 days after discontinuation or after ...

  7. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  8. Vitamin A - Mayo Clinic

    Examples include the creams isotretinoin and etretinate. Interactions. Possible interactions include: Hepatotoxic medicines. Taking high doses of vitamin A ...

  9. Tigecycline (intravenous route) - Side effects & uses - Mayo Clinic

    Isotretinoin; Levoketoconazole; Levonorgestrel; Magnesium Sulfate; Meloxicam; Mercaptopurine; Mestranol; Methicillin; Methotrexate; Nafcillin; Nomegestrol ...

  10. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial - Mayo Clinic

    Current or planned use of methoxyflurane, oral contraceptives, isotretinoin, penicillin, or ergot alkaloids. Participating Mayo Clinic locations. Study ...